Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
The global Antiblocking Agents market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Antiblocking Agents is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Antiblocking Agents is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Antiblocking Agents is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Antiblocking Agents include Evonik, WR Grace, Minerals Technologies, Croda, PQ Corporation, Madhu Silica, Solvay, Fuji Silysia and IQE Group, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Antiblocking Agents production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
In terms of consumption side, this report focuses on the sales of Antiblocking Agents by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2029.
Report Includes:
This report presents an overview of global market for Antiblocking Agents, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Antiblocking Agents, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Antiblocking Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antiblocking Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Antiblocking Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Antiblocking Agents sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Evonik, WR Grace, Minerals Technologies, Croda, PQ Corporation, Madhu Silica, Solvay, Fuji Silysia and IQE Group, etc.
By Company
Evonik
WR Grace
Minerals Technologies
Croda
PQ Corporation
Madhu Silica
Solvay
Fuji Silysia
IQE Group
Tosoh Silica
NYACOL Nano Technologies
S-Chemtech
Baerlocher
Imerys
Hoffmann Mineral
EP Mineral
Segment by Type
Organic
Inorganic
Segment by Application
PE Films
PP Films
Others
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Antiblocking Agents production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Antiblocking Agents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Antiblocking Agents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antiblocking Agents sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Antiblocking Agents Product Introduction
1.2 Market by Type
1.2.1 Global Antiblocking Agents Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Organic
1.2.3 Inorganic
1.3 Market by Application
1.3.1 Global Antiblocking Agents Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 PE Films
1.3.3 PP Films
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Antiblocking Agents Production
2.1 Global Antiblocking Agents Production Capacity (2018-2029)
2.2 Global Antiblocking Agents Production by Region: 2018 VS 2022 VS 2029
2.3 Global Antiblocking Agents Production by Region
2.3.1 Global Antiblocking Agents Historic Production by Region (2018-2023)
2.3.2 Global Antiblocking Agents Forecasted Production by Region (2024-2029)
2.3.3 Global Antiblocking Agents Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Antiblocking Agents Revenue Estimates and Forecasts 2018-2029
3.2 Global Antiblocking Agents Revenue by Region
3.2.1 Global Antiblocking Agents Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Antiblocking Agents Revenue by Region (2018-2023)
3.2.3 Global Antiblocking Agents Revenue by Region (2024-2029)
3.2.4 Global Antiblocking Agents Revenue Market Share by Region (2018-2029)
3.3 Global Antiblocking Agents Sales Estimates and Forecasts 2018-2029
3.4 Global Antiblocking Agents Sales by Region
3.4.1 Global Antiblocking Agents Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Antiblocking Agents Sales by Region (2018-2023)
3.4.3 Global Antiblocking Agents Sales by Region (2024-2029)
3.4.4 Global Antiblocking Agents Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Antiblocking Agents Sales by Manufacturers
4.1.1 Global Antiblocking Agents Sales by Manufacturers (2018-2023)
4.1.2 Global Antiblocking Agents Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antiblocking Agents in 2022
4.2 Global Antiblocking Agents Revenue by Manufacturers
4.2.1 Global Antiblocking Agents Revenue by Manufacturers (2018-2023)
4.2.2 Global Antiblocking Agents Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Antiblocking Agents Revenue in 2022
4.3 Global Antiblocking Agents Sales Price by Manufacturers
4.4 Global Key Players of Antiblocking Agents, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Antiblocking Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Antiblocking Agents, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Antiblocking Agents, Product Offered and Application
4.8 Global Key Manufacturers of Antiblocking Agents, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Antiblocking Agents Sales by Type
5.1.1 Global Antiblocking Agents Historical Sales by Type (2018-2023)
5.1.2 Global Antiblocking Agents Forecasted Sales by Type (2024-2029)
5.1.3 Global Antiblocking Agents Sales Market Share by Type (2018-2029)
5.2 Global Antiblocking Agents Revenue by Type
5.2.1 Global Antiblocking Agents Historical Revenue by Type (2018-2023)
5.2.2 Global Antiblocking Agents Forecasted Revenue by Type (2024-2029)
5.2.3 Global Antiblocking Agents Revenue Market Share by Type (2018-2029)
5.3 Global Antiblocking Agents Price by Type
5.3.1 Global Antiblocking Agents Price by Type (2018-2023)
5.3.2 Global Antiblocking Agents Price Forecast by Type (2024-2029)
6 Market Size by Application
6.1 Global Antiblocking Agents Sales by Application
6.1.1 Global Antiblocking Agents Historical Sales by Application (2018-2023)
6.1.2 Global Antiblocking Agents Forecasted Sales by Application (2024-2029)
6.1.3 Global Antiblocking Agents Sales Market Share by Application (2018-2029)
6.2 Global Antiblocking Agents Revenue by Application
6.2.1 Global Antiblocking Agents Historical Revenue by Application (2018-2023)
6.2.2 Global Antiblocking Agents Forecasted Revenue by Application (2024-2029)
6.2.3 Global Antiblocking Agents Revenue Market Share by Application (2018-2029)
6.3 Global Antiblocking Agents Price by Application
6.3.1 Global Antiblocking Agents Price by Application (2018-2023)
6.3.2 Global Antiblocking Agents Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Antiblocking Agents Market Size by Type
7.1.1 US & Canada Antiblocking Agents Sales by Type (2018-2029)
7.1.2 US & Canada Antiblocking Agents Revenue by Type (2018-2029)
7.2 US & Canada Antiblocking Agents Market Size by Application
7.2.1 US & Canada Antiblocking Agents Sales by Application (2018-2029)
7.2.2 US & Canada Antiblocking Agents Revenue by Application (2018-2029)
7.3 US & Canada Antiblocking Agents Sales by Country
7.3.1 US & Canada Antiblocking Agents Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Antiblocking Agents Sales by Country (2018-2029)
7.3.3 US & Canada Antiblocking Agents Revenue by Country (2018-2029)
7.3.4 United States
7.3.5 Canada
8 Europe
8.1 Europe Antiblocking Agents Market Size by Type
8.1.1 Europe Antiblocking Agents Sales by Type (2018-2029)
8.1.2 Europe Antiblocking Agents Revenue by Type (2018-2029)
8.2 Europe Antiblocking Agents Market Size by Application
8.2.1 Europe Antiblocking Agents Sales by Application (2018-2029)
8.2.2 Europe Antiblocking Agents Revenue by Application (2018-2029)
8.3 Europe Antiblocking Agents Sales by Country
8.3.1 Europe Antiblocking Agents Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Antiblocking Agents Sales by Country (2018-2029)
8.3.3 Europe Antiblocking Agents Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Antiblocking Agents Market Size by Type
9.1.1 China Antiblocking Agents Sales by Type (2018-2029)
9.1.2 China Antiblocking Agents Revenue by Type (2018-2029)
9.2 China Antiblocking Agents Market Size by Application
9.2.1 China Antiblocking Agents Sales by Application (2018-2029)
9.2.2 China Antiblocking Agents Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Antiblocking Agents Market Size by Type
10.1.1 Asia Antiblocking Agents Sales by Type (2018-2029)
10.1.2 Asia Antiblocking Agents Revenue by Type (2018-2029)
10.2 Asia Antiblocking Agents Market Size by Application
10.2.1 Asia Antiblocking Agents Sales by Application (2018-2029)
10.2.2 Asia Antiblocking Agents Revenue by Application (2018-2029)
10.3 Asia Antiblocking Agents Sales by Region
10.3.1 Asia Antiblocking Agents Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Antiblocking Agents Revenue by Region (2018-2029)
10.3.3 Asia Antiblocking Agents Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Antiblocking Agents Market Size by Type
11.1.1 Middle East, Africa and Latin America Antiblocking Agents Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Antiblocking Agents Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Antiblocking Agents Market Size by Application
11.2.1 Middle East, Africa and Latin America Antiblocking Agents Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Antiblocking Agents Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Antiblocking Agents Sales by Country
11.3.1 Middle East, Africa and Latin America Antiblocking Agents Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Antiblocking Agents Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Antiblocking Agents Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Evonik
12.1.1 Evonik Company Information
12.1.2 Evonik Overview
12.1.3 Evonik Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Evonik Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Evonik Recent Developments
12.2 WR Grace
12.2.1 WR Grace Company Information
12.2.2 WR Grace Overview
12.2.3 WR Grace Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 WR Grace Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 WR Grace Recent Developments
12.3 Minerals Technologies
12.3.1 Minerals Technologies Company Information
12.3.2 Minerals Technologies Overview
12.3.3 Minerals Technologies Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Minerals Technologies Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Minerals Technologies Recent Developments
12.4 Croda
12.4.1 Croda Company Information
12.4.2 Croda Overview
12.4.3 Croda Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Croda Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Croda Recent Developments
12.5 PQ Corporation
12.5.1 PQ Corporation Company Information
12.5.2 PQ Corporation Overview
12.5.3 PQ Corporation Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 PQ Corporation Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 PQ Corporation Recent Developments
12.6 Madhu Silica
12.6.1 Madhu Silica Company Information
12.6.2 Madhu Silica Overview
12.6.3 Madhu Silica Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Madhu Silica Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Madhu Silica Recent Developments
12.7 Solvay
12.7.1 Solvay Company Information
12.7.2 Solvay Overview
12.7.3 Solvay Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Solvay Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Solvay Recent Developments
12.8 Fuji Silysia
12.8.1 Fuji Silysia Company Information
12.8.2 Fuji Silysia Overview
12.8.3 Fuji Silysia Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.8.4 Fuji Silysia Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Fuji Silysia Recent Developments
12.9 IQE Group
12.9.1 IQE Group Company Information
12.9.2 IQE Group Overview
12.9.3 IQE Group Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.9.4 IQE Group Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 IQE Group Recent Developments
12.10 Tosoh Silica
12.10.1 Tosoh Silica Company Information
12.10.2 Tosoh Silica Overview
12.10.3 Tosoh Silica Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.10.4 Tosoh Silica Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Tosoh Silica Recent Developments
12.11 NYACOL Nano Technologies
12.11.1 NYACOL Nano Technologies Company Information
12.11.2 NYACOL Nano Technologies Overview
12.11.3 NYACOL Nano Technologies Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.11.4 NYACOL Nano Technologies Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 NYACOL Nano Technologies Recent Developments
12.12 S-Chemtech
12.12.1 S-Chemtech Company Information
12.12.2 S-Chemtech Overview
12.12.3 S-Chemtech Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.12.4 S-Chemtech Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 S-Chemtech Recent Developments
12.13 Baerlocher
12.13.1 Baerlocher Company Information
12.13.2 Baerlocher Overview
12.13.3 Baerlocher Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.13.4 Baerlocher Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Baerlocher Recent Developments
12.14 Imerys
12.14.1 Imerys Company Information
12.14.2 Imerys Overview
12.14.3 Imerys Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.14.4 Imerys Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Imerys Recent Developments
12.15 Hoffmann Mineral
12.15.1 Hoffmann Mineral Company Information
12.15.2 Hoffmann Mineral Overview
12.15.3 Hoffmann Mineral Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.15.4 Hoffmann Mineral Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Hoffmann Mineral Recent Developments
12.16 EP Mineral
12.16.1 EP Mineral Company Information
12.16.2 EP Mineral Overview
12.16.3 EP Mineral Antiblocking Agents Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.16.4 EP Mineral Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 EP Mineral Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Antiblocking Agents Industry Chain Analysis
13.2 Antiblocking Agents Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Antiblocking Agents Production Mode & Process
13.4 Antiblocking Agents Sales and Marketing
13.4.1 Antiblocking Agents Sales Channels
13.4.2 Antiblocking Agents Distributors
13.5 Antiblocking Agents Customers
14 Antiblocking Agents Market Dynamics
14.1 Antiblocking Agents Industry Trends
14.2 Antiblocking Agents Market Drivers
14.3 Antiblocking Agents Market Challenges
14.4 Antiblocking Agents Market Restraints
15 Key Finding in The Global Antiblocking Agents Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Evonik
WR Grace
Minerals Technologies
Croda
PQ Corporation
Madhu Silica
Solvay
Fuji Silysia
IQE Group
Tosoh Silica
NYACOL Nano Technologies
S-Chemtech
Baerlocher
Imerys
Hoffmann Mineral
EP Mineral
*If Applicable.